Andrew Mulberg

No open positions remaining

Consumer Services

Health Technology

Government

Profile

Andrew E.
Mulberg is currently SVP-Regulatory Affairs & Quality Assurance at Neurogene, Inc. since 2020.
Formerly, Dr. Mulberg was Division Deputy Director-Gastroenterology at the US Food & Drug Administration and Vice President-Regulatory Affairs at Amicus Therapeutics, Inc. Education includes an undergraduate degree from The Trustees of Columbia University in The City of New York and a doctorate from Icahn School of Medicine at Mount Sinai.

Andrew Mulberg active positions

Companies	Position	Start

All active positions of Andrew Mulberg

Former positions of Andrew Mulberg

Companies	Position	End
US Food & Drug Administration US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services	Corporate Officer/Principal	-
AMICUS THERAPEUTICS, INC.	General Counsel	-

See the detail of Andrew Mulberg's experience

Training of Andrew Mulberg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Mulberg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Amicus Therapeutics, Inc. Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases	Health Technology
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
US Food & Drug Administration US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services	Government
Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services